| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | Tubridy Karen L | SVP, Chief Development Officer | Feb 28, 2020 | Sale | $8.70 | 3,454 | 30,050 | 84,679 | Mar 02, 2020, 07:26 PM | |
| AKBA | Akebia Therapeutics, Inc. | Tubridy Karen L | SVP, Chief Development Officer | Apr 11, 2019 | Option Exercise | $7.70 | 6,075 | 46,777 | 55,324 | Apr 12, 2019, 04:00 PM | |
| AKBA | Akebia Therapeutics, Inc. | Tubridy Karen L | SVP, Chief Development Officer | Dec 12, 2018 | Option Exercise | $8.94 | 11,928 | 106,636 | 30,229 | Dec 13, 2018, 08:18 AM | |
| EBIO | Eleven Biotherapeutics, Inc. | Tubridy Karen L | Chief Development Officer | Jun 27, 2016 | Sale | $2.08 | 4,372 | 9,094 | 32,753 | Jun 29, 2016, 04:16 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | Tubridy Karen L | Chief Development Officer | Dec 28, 2015 | Sale | $2.85 | 4,427 | 12,617 | 32,973 | Dec 30, 2015, 04:04 PM |
Menu